Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1990;10:577-581

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuster, H.
Right arrow Articles by Zollner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuster, H.
Right arrow Articles by Zollner, N.

Arteriosclerosis, Vol 10, 577-581, Copyright © 1990 by American Heart Association


ARTICLES

Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich

H Schuster, G Rauh, B Kormann, T Hepp, S Humphries, C Keller, G Wolfram and N Zollner
Medizinische Poliklinik der Universitat, Munchen, F.R.G.

It has recently been suggested that a substitution of glutamine for arginine at residue 3500 of apolipoprotein (apo) B-100 causes familial defective apo B-100 (FDB), an autosomal, dominantly inherited disorder, which leads to increased serum cholesterol levels. From a sample of 243 patients from Munich with type IIa hyperlipoproteinemia (HL), we have identified eight individuals with the apo B-100 arginine(3500)---- glutamine mutation. In a group of 57 subjects with defective low density lipoprotein receptor (LDLR), no mutant apo B alleles were detected. The frequency of FDB in patients with type IIa HL was estimated to be 3%. In the kindreds of three of the probands, 10 additional carriers of the apo B mutation were identified. Clinical and biochemical data reveal a striking similarity between patients with FDB and those with a defect in the LDLR gene. Our data support previous findings that FDB is a serious disorder causing premature atherosclerosis.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
N. Jacobsen, M. Fenger, J. Bentzen, S. L. Rasmussen, M. H. Jakobsen, J. Fenstholt, and J. Skouv
Genotyping of the Apolipoprotein B R3500Q Mutation Using Immobilized Locked Nucleic Acid Capture Probes
Clin. Chem., April 1, 2002; 48(4): 657 - 660.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Raungaard, F. Heath, P. S. Hansen, J. U. Brorholt-Petersen, H. K. Jensen, and O. Fargeman
Flow Cytometric Assessment of LDL Ligand Function for Detection of Heterozygous Familial Defective Apolipoprotein B-100
Clin. Chem., February 1, 2000; 46(2): 224 - 233.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Aslanidis and G. Schmitz
High-Speed Apolipoprotein E Genotyping and Apolipoprotein B3500 Mutation Detection Using Real-Time Fluorescence PCR and Melting Curves
Clin. Chem., July 1, 1999; 45(7): 1094 - 1097.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. R. Miserez and U. Keller
Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1719 - 1729.
[Abstract] [Full Text]


Home page
CirculationHome page
E. A.L. Biessen, H. Vietsch, and T. J.C. Van Berkel
Cholesterol Derivative of a New Triantennary Cluster Galactoside Lowers Serum Cholesterol Levels and Enhances Secretion of Bile Acids in the Rat
Circulation, March 15, 1995; 91(6): 1847 - 1854.
[Abstract] [Full Text]